Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Avantogen Oncology, Inc.    AVTO

AVANTOGEN ONCOLOGY, INC. (AVTO)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 06/06 07:38:33 pm
0.005 USD   -55.75%
 SummaryQuotesChartsCompany 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
02/16/2018 03/09/2018 03/14/2018 04/05/2018 06/06/2018 Date
0.012(c) 0.005(c) 0.012(c) 0.0113(c) 0.005(c) Last
2 400 13 000 4 000 1 000 20 000 Volume
0.00% -58.33% +140.00% -5.83% -55.75% Change
More quotes
Company
Avantogen Oncology, Inc. operates as a development stage company.It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer.The company was founded in 1986 and is headquartered in Los Angeles, CA. 
More about the company
Latest news on AVANTOGEN ONCOLOGY, INC.

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
02:02aLatecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
06/13Sanofi says on track to regain solid position in cancer drugs
RE
06/12GSK says vaccine business president to leave by year-end
RE
06/06Drugmaker Lundbeck to settle U.S. charity probe for $52.6 million
RE
More sector news : Biotechnology & Medical Research - NEC
Chart AVANTOGEN ONCOLOGY, INC.
Duration : Period :
Avantogen Oncology, Inc. Technical Analysis Chart | AVTO | US05350Y1001 | 4-Traders
Managers
NameTitle
William J. Ardrey Chairman, President & Chief Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
AVANTOGEN ONCOLOGY, INC.0.00%0
CELLTRION, INC.--.--%33 912
IQVIA HOLDINGS INC7.13%21 394
LONZA GROUP3.38%20 435
INCYTE CORPORATION-21.91%15 677
ALNYLAM PHARMACEUTICALS, INC.-15.15%10 836